Vitamin D Level in SLE Patients with or without Renal Involvement and its Relationship with Disease Activity (SLEDAI)

Read full text Summarise with VIRAT
Authors: Farnaz Nobi, Dr. Khaleda Akhter, Shanjida Sultana Juthy, Samira Khatun, Madhabi Karmaker
Cited by: 0
References: 21

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by multisystem involvement, with lupus nephritis (LN) being a major complication.Vitamin D, known for its immunomodulatory properties, has been implicated in SLE pathogenesis, with deficiency potentially contributing to increased disease activity. Aim of the study:This study aimed to evaluate serum vitamin D levels in SLE patients with and without renal involvement and investigate their correlation with disease activity, as measured by the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI).Methods: A cross-sectional study was conducted at Dhaka Medical College Hospital, Bangladesh, over one year (April 2018-March 2019).A total of 130 participants were enrolled, including SLE patients with nephropathy (n=50), SLE patients without nephropathy (n=50), and healthy controls (n=30).Serum vitamin D levels were measured and compared across groups, and correlations with disease activity were assessed using statistical analyses.Result: Vitamin D levels were significantly lower in SLE patients with nephropathy (14.92 ± 3.76 ng/mL) compared to those without nephropathy (19.65 ± 6.15 ng/mL) and healthy controls (23.95 ± 8.81 ng/mL) (p

Fields of Study & Subjects

Systemic Lupus Erythematosus Research Vitamin D Research Studies Systemic Sclerosis and Related Diseases

Publication details

Journal / source
Archives of Nephrology and Urology
Volume
9
Issue
1
Publication date
1 January 2026
Language
EN